“Examining the Implications of Drug Importation”

July 13, 2004

NOTICE OF HEARING

ROOM CHANGE - HART 216

The Senate Committee on the Judiciary will hold a hearing on Wednesday, July 14, 2004, at 10:00 a.m. in Room 216 of the
Senate Hart Office Building on "Examining the Implications of Drug Importation."

By order of the Chairman

Chairman Hatch will preside.

---------

Final Witness List

Hearing before the
Senate Judiciary Committee
on
"Examining the Implications of Drug Importation"

Wednesday, July 14, 2004 at 10:00 a.m.
Hart Senate Office Building Room 216

Panel I:

The Honorable Bernie Sanders
Member of the U.S. House of Representatives

The Honorable Don Nickles
United States Senator

The Honorable Bryon Dorgan
United States Senator

The Honorable John Breaux
United States Senator

Panel II:

William K. Hubbard
Associate Commissioner for Policy and Planning
U.S. Food and Drug Administration

John Taylor, III
Associate Commissioner for Regulatory Affairs
U.S. Food and Drug Administration

Ms. Elizabeth G. Durant
Executive Director of Trade Compliance and Facilitation, Office of Field Operations at the Bureau of Customs and Border Protection (CBP)

Panel III:

The Honorable Rudolph W. Giuliani
Former Mayor of New York City
Chairman and CEO, Giuliani Partners LLC

Mr. Carmen A. Catizone, M.S., RPh, DPh
Executive Director/Secretary
National Association of Boards of Pharmacy Boards

Dr. Elizabeth A. Wennar, M.P.H, D.H.A.
President and CEO, United Health Alliance of Bennington, VT and Principal, HealthInova of Manchester, VT
United Health Alliance

Ms. Joanna Disch, Ph.D.
Board Member, AARP

Professor Stephen W. Schondelmeyer, Ph.D.
Professor of Pharmaceutical Economics
University of Minnesota College of Pharmacy

Kathleen Jaeger
President and CEO
Generic Pharmaceutical Association